137 related articles for article (PubMed ID: 10592714)
1. [Adherence and invasion-two pathogenicity factors in bacterial and fungal pathogens].
Müller FM; Morschhäuser J; Köhler G; Oelschlaeger TA; Ziebuhr W; Hacker J
Mycoses; 1999; 42 Suppl 1():39-42. PubMed ID: 10592714
[TBL] [Abstract][Full Text] [Related]
2. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of the Adhesin Gene EPA1 Mediated by PDR1 in Candida glabrata Leads to Enhanced Host Colonization.
Vale-Silva LA; Moeckli B; Torelli R; Posteraro B; Sanguinetti M; Sanglard D
mSphere; 2016; 1(2):. PubMed ID: 27303714
[TBL] [Abstract][Full Text] [Related]
4. Pathogenicity and drug resistance in Candida albicans and other yeast species. A review.
Mishra NN; Prasad T; Sharma N; Payasi A; Prasad R; Gupta DK; Singh R
Acta Microbiol Immunol Hung; 2007 Sep; 54(3):201-35. PubMed ID: 17896473
[TBL] [Abstract][Full Text] [Related]
5. Adhesins in human fungal pathogens: glue with plenty of stick.
de Groot PW; Bader O; de Boer AD; Weig M; Chauhan N
Eukaryot Cell; 2013 Apr; 12(4):470-81. PubMed ID: 23397570
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients.
Perea S; López-Ribot JL; Kirkpatrick WR; McAtee RK; Santillán RA; Martínez M; Calabrese D; Sanglard D; Patterson TF
Antimicrob Agents Chemother; 2001 Oct; 45(10):2676-84. PubMed ID: 11557454
[TBL] [Abstract][Full Text] [Related]
7. Selected mechanisms of molecular resistance of Candida albicans to azole drugs.
Gołąbek K; Strzelczyk JK; Owczarek A; Cuber P; Ślemp-Migiel A; Wiczkowski A
Acta Biochim Pol; 2015; 62(2):247-51. PubMed ID: 25901298
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of bacterial pathogenicity.
Wilson JW; Schurr MJ; LeBlanc CL; Ramamurthy R; Buchanan KL; Nickerson CA
Postgrad Med J; 2002 Apr; 78(918):216-24. PubMed ID: 11930024
[TBL] [Abstract][Full Text] [Related]
9. Host-bacteria interaction and adhesin study for development of therapeutics.
Solanki V; Tiwari M; Tiwari V
Int J Biol Macromol; 2018 Jun; 112():54-64. PubMed ID: 29414732
[TBL] [Abstract][Full Text] [Related]
10. Bacterial adhesins, the pathogenic weapons to trick host defense arsenal.
Patel S; Mathivanan N; Goyal A
Biomed Pharmacother; 2017 Sep; 93():763-771. PubMed ID: 28709130
[TBL] [Abstract][Full Text] [Related]
11. Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance.
Silva S; Negri M; Henriques M; Oliveira R; Williams DW; Azeredo J
FEMS Microbiol Rev; 2012 Mar; 36(2):288-305. PubMed ID: 21569057
[TBL] [Abstract][Full Text] [Related]
12. CgPDR1 gain-of-function mutations lead to azole-resistance and increased adhesion in clinical Candida glabrata strains.
Ni Q; Wang C; Tian Y; Dong D; Jiang C; Mao E; Peng Y
Mycoses; 2018 Jul; 61(7):430-440. PubMed ID: 29464833
[TBL] [Abstract][Full Text] [Related]
13. Adhesins and invasins of pathogenic bacteria: a structural view.
Niemann HH; Schubert WD; Heinz DW
Microbes Infect; 2004 Jan; 6(1):101-12. PubMed ID: 14738899
[TBL] [Abstract][Full Text] [Related]
14. Epidemiological investigation of non-albicans Candida species recovered from mycotic mastitis of cows in Yinchuan, Ningxia of China.
Du J; Wang X; Luo H; Wang Y; Liu X; Zhou X
BMC Vet Res; 2018 Aug; 14(1):251. PubMed ID: 30157847
[TBL] [Abstract][Full Text] [Related]
15. Nucleotide substitutions in the Candida albicans ERG11 gene of azole-susceptible and azole-resistant clinical isolates.
Strzelczyk JK; Slemp-Migiel A; Rother M; Gołąbek K; Wiczkowski A
Acta Biochim Pol; 2013; 60(4):547-52. PubMed ID: 24340302
[TBL] [Abstract][Full Text] [Related]
16. Bacterial adhesins: function and structure.
Klemm P; Schembri MA
Int J Med Microbiol; 2000 Mar; 290(1):27-35. PubMed ID: 11043979
[TBL] [Abstract][Full Text] [Related]
17. Common themes in microbial pathogenicity revisited.
Finlay BB; Falkow S
Microbiol Mol Biol Rev; 1997 Jun; 61(2):136-69. PubMed ID: 9184008
[TBL] [Abstract][Full Text] [Related]
18. Stepwise emergence of azole, echinocandin and amphotericin B multidrug resistance in vivo in Candida albicans orchestrated by multiple genetic alterations.
Jensen RH; Astvad KM; Silva LV; Sanglard D; Jørgensen R; Nielsen KF; Mathiasen EG; Doroudian G; Perlin DS; Arendrup MC
J Antimicrob Chemother; 2015 Sep; 70(9):2551-5. PubMed ID: 26017038
[TBL] [Abstract][Full Text] [Related]
19. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
20. The cellular and molecular defense mechanisms of the Candida yeasts against azole antifungal drugs.
Noël T
J Mycol Med; 2012 Jun; 22(2):173-8. PubMed ID: 23518020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
